Mobilizing Endogenous Progenitor Cells Using pSDF1α-Activated Scaffolds Accelerates Angiogenesis and Bone Repair in...

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Tissue Engineering

Background:

• Mobilizing endogenous progenitor cells for in situ tissue repair is key for regenerative medicine.
• Vascularization is crucial for the survival of newly generated tissue.
• Gene-activated scaffolds offer a promising strategy for enhancing tissue regeneration.

Purpose of the Study:

• To develop and evaluate a gene-activated scaffold for enhanced tissue regeneration.
• To investigate the role of stromal derived factor 1α (SDF1α) in cell recruitment and angiogenesis.
• To assess the efficacy of gene-activated scaffolds in promoting bone defect healing.

Main Methods:

• Fabrication of a gene-activated scaffold containing a stromal derived factor 1α plasmid (pSDF1α).
• In vitro assessment of SDF1α protein effects on mesenchymal stromal cell (MSC) recruitment and endothelial cell behavior.
• Subcutaneous and calvarial critical-sized bone defect implantation in vivo.
• Transcriptomic analysis to evaluate cellular responses, angiogenesis, and osteogenesis.

Main Results:

• Over-expression of SDF1α enhanced MSC recruitment and induced vessel-like structure formation in vitro.
• Implanted pSDF1α scaffolds recruited endogenous MSCs and stimulated angiogenesis.
• Scaffolds activated angiogenic and osteogenic programs, upregulating key genes (Runx2, Dlx5, Sp7).
• Both pSDF1α and pVEGF scaffolds led to complete bridging of critical-sized bone defects within 4 weeks.

Conclusions:

• Cell-free gene-activated scaffolds can harness and enhance the body's regenerative capacity.
• SDF1α plays a significant role in recruiting MSCs and promoting angiogenesis for tissue repair.
• This versatile scaffold technology holds immense potential for various regenerative medicine applications.